tiprankstipranks
Trending News
More News >
NervGen Pharma (TSE:NGEN)
:NGEN
Canadian Market
Advertisement

NervGen Pharma (NGEN) Technical Analysis

Compare
50 Followers

Summary of all the Indicators

Overall Consensus
Sell
7Bullish
2Neutral
13Bearish
Technical Analysis Consensus
Buy
5Bullish
2Neutral
3Bearish
Moving Average Consensus
Strong Sell
2Bullish
0Neutral
10Bearish
NervGen Pharma’s (NGEN) Moving Averages Convergence Divergence (MACD) indicator is 0.03, suggesting NervGen Pharma is a Buy.
NervGen Pharma’s (NGEN) 20-Day exponential moving average is 3.57, while NervGen Pharma’s (NGEN) share price is C$3.4, making it a Sell.
NervGen Pharma’s (NGEN) 50-Day exponential moving average is 3.53, while NervGen Pharma’s (NGEN) share price is C$3.4, making it a Sell.

NervGen Pharma (NGEN) Pivot Points

Sep 27, 2025, 08:34 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
3.37
3.43
3.48
3.54
3.59
3.65
3.70
Fibonacci
3.43
3.47
3.50
3.54
3.58
3.61
3.65
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

NervGen Pharma (NGEN) Moving Averages

Sep 27, 2025, 08:34 PM
Period
Simple
Exponential
MA5
3.54Sell
3.54Sell
MA10
3.62Sell
3.58Sell
MA20
3.62Sell
3.57Sell
MA50
3.47Sell
3.53Sell
MA100
3.72Sell
3.49Sell
MA200
3.30Buy
3.23Buy
NervGen Pharma’s (NGEN) 10-Day exponential moving average is 3.58, while NervGen Pharma’s (NGEN) share price is C$3.4, making it a Sell.
NervGen Pharma’s (NGEN) 100-Day exponential moving average is 3.49, while NervGen Pharma’s (NGEN) share price is C$3.4, making it a Sell.
NervGen Pharma’s (NGEN) stock price is C$3.4 and NervGen Pharma’s (NGEN) 50-day simple moving average is 3.47, creating a Sell signal.
NervGen Pharma’s (NGEN) stock price is C$3.4 and NervGen Pharma’s (NGEN) 100-day simple moving average is 3.72, creating a Sell signal.
NervGen Pharma’s (NGEN) stock price is C$3.4 and NervGen Pharma’s (NGEN) 200-day simple moving average is 3.30, creating a Buy signal.

NervGen Pharma (NGEN) Technical Indicators

Sep 27, 2025, 08:34 PM
Name
Value
Implied Action
RSI (14)
46.34
Neutral
STOCH (9,6)
7.50
Buy
STOCHRSI (14)
7.50
Buy
MACD (12,26)
0.03
Buy
ADX (14)
21.39
Neutral
Williams %R
-100.00
Buy
CCI (14)
-110.76
Buy
ATR (14)
0.19
-
Ultimate Oscillator
28.63
Sell
ROC
-1.70
Sell
NervGen Pharma’s (NGEN) Relative Strength Index (RSI) is 46.34, creating a Neutral signal.
NervGen Pharma’s (NGEN) Trend Strength Indicator (ADX) is 21.39, creating a Neutral signal.
NervGen Pharma’s (NGEN) Commodity Channel Index (CCI) is -110.76, creating a Buy signal.
NervGen Pharma’s (NGEN) Price Rate of Change (ROC) is -1.70, creating a Sell signal.

FAQ

Is NGEN a Buy, Hold, or Sell?
Based on NGEN’s technical indicators, NGEN is a Sell.
    What is NGEN’s RSI (14)?
    NGEN’s RSI (14) is 46.34, which suggests NGEN is a Neutral.
      What is NGEN’s MACD?
      NGEN’s MACD is 0.03, which suggests NGEN is a Buy.
        What is NGEN’s 5-day moving average?
        NGEN’s 5-day moving average is 3.54, which suggests NGEN is a Sell.
          What is NGEN’s 20-day moving average?
          NGEN 20-day moving average is 3.62, which suggests NGEN is a Sell.
            What is NGEN’s 50-day moving average?
            NGEN’s 50-day moving average is 3.47, which suggests NGEN is a Sell.
              What is NGEN’s 200-day moving average?
              NGEN’s 200-day moving average is 3.30, which suggests NGEN is a Buy.
                What is NGEN’s Williams % R (14)?
                NGEN’s Williams % R (14) is -100.00, which suggests NGEN is a Buy.
                  What is NGEN’s CCI (14)?
                  NGEN’s CCI (14) is -110.76, which suggests NGEN is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis